CSIMarket Company Name, Ticker, Industry, else..
 
Macrogenics Inc   (NASDAQ: MGNX)
 

Macrogenics Inc's Suppliers Performance

MGNX's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
MGNX Costs vs Sales of Suppliers Growth

• More on MGNX Suppliers






Macrogenics Inc's Comment on Supply Chain


The company sources raw materials primarily from a single supplier for each material or product and maintains inventory levels to mitigate supply interruptions. However, it acknowledges risks from prolonged supplier failures or national supply chain disruptions. Production of biological therapeutic products involves complex and regulated processes, making changes in manufacturing capacity time-consuming and costly. Extended shutdowns or failures at the company’s own facilities or contract manufacturers could disrupt product supply. In November 2020, the company partnered with Eversana to commercialize margetuximab in the U.S., retaining manufacturing, regulatory, and development responsibilities while Eversana provided marketing and commercial services and shared commercialization expenses. In November 2024, the company sold global rights to MARGENZA to TerSera and paid Eversana an amendment fee related to this sale. The company intends to commercialize future approved products outside the U.S. through third-party partners or potentially develop internal capabilities within the U.S. if necessary.

Macrogenics Inc's Comment on Supply Chain


The company sources raw materials primarily from a single supplier for each material or product and maintains inventory levels to mitigate supply interruptions. However, it acknowledges risks from prolonged supplier failures or national supply chain disruptions. Production of biological therapeutic products involves complex and regulated processes, making changes in manufacturing capacity time-consuming and costly. Extended shutdowns or failures at the company’s own facilities or contract manufacturers could disrupt product supply. In November 2020, the company partnered with Eversana to commercialize margetuximab in the U.S., retaining manufacturing, regulatory, and development responsibilities while Eversana provided marketing and commercial services and shared commercialization expenses. In November 2024, the company sold global rights to MARGENZA to TerSera and paid Eversana an amendment fee related to this sale. The company intends to commercialize future approved products outside the U.S. through third-party partners or potentially develop internal capabilities within the U.S. if necessary.







MGNX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Macrogenics Inc 237.84 167.67 -14.59 293
SUBTOTAL 0.00 0.00 0.00 -


Sources: Macrogenics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Macrogenics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.